DAA2153 |
complement component 4A increases with age |
Molecular |
frontal lobe |
Human |
C4A |
187.3% Increase Gene Expression Level |
|
DAA2326 |
major histocompatibility complex, class II, DR alpha increases with age |
Molecular |
frontal lobe |
Human |
HLA-DRA |
146.8% Increase Gene Expression Level |
|
DAA2369 |
major histocompatibility complex, class II, DR alpha increases with age |
Molecular |
frontal lobe |
Human |
HLA-DRA |
135.3% Increase Gene Expression Level |
|
DAA2307 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
frontal lobe |
Human |
CX3CL1 |
61.1% Decrease Gene Expression Level |
|
DAA2308 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
frontal lobe |
Human |
CX3CL1 |
58.0% Decrease Gene Expression Level |
|
DAA2248 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
Molecular |
frontal lobe |
Human |
CASP1 |
30.2% Increase Gene Expression Level |
|
DAA2195 |
complement component 1, q subcomponent, B chain increases with age |
Molecular |
frontal lobe |
Human |
C1QB |
166.8% Increase Gene Expression Level |
|
DAA2289 |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide increases with age |
Molecular |
frontal lobe |
Human |
FCER1G |
105.3% Increase Gene Expression Level |
|
DAA2309 |
chemokine (C-X-C motif) ligand 16 increases with age |
Molecular |
frontal lobe |
Human |
CXCL16 |
44.1% Increase Gene Expression Level |
|
DAA2144 |
Fc fragment of IgG, high affinity Ia, receptor (CD64) increases with age |
Molecular |
frontal lobe |
Human |
FCGR1A |
157.3% Increase Gene Expression Level |
|
DAA2145 |
Fc fragment of IgG, high affinity Ib, receptor (CD64) increases with age |
Molecular |
frontal lobe |
Human |
FCGR1B |
170.4% Increase Gene Expression Level |
|
DAA2196 |
complement component 1, q subcomponent, C chain increases with age |
Molecular |
frontal lobe |
Human |
C1QC |
126.1% Increase Gene Expression Level |
|
DAA2162 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
Molecular |
frontal lobe |
Human |
FCGR3B |
261.1% Increase Gene Expression Level |
|
DAA2287 |
CD163 molecule increases with age |
Molecular |
frontal lobe |
Human |
CD163 |
283.0% Increase Gene Expression Level |
|
DAA2197 |
complement component 1, s subcomponent increases with age |
Molecular |
frontal lobe |
Human |
C1S |
71.9% Increase Gene Expression Level |
|
DAA2288 |
CD163 molecule increases with age |
Molecular |
frontal lobe |
Human |
CD163 |
383.1% Increase Gene Expression Level |
|
DAA2379 |
major histocompatibility complex, class I, B increases with age |
Molecular |
frontal lobe |
Human |
HLA-B |
39.0% Increase Gene Expression Level |
|
DAA2202 |
Clusterin increases with age |
Molecular |
frontal lobe |
Human |
CLU |
30.9% Increase Gene Expression Level |
|
DAA2203 |
Clusterin increases with age |
Molecular |
frontal lobe |
Human |
CLU |
56.5% Increase Gene Expression Level |
|
DAA2201 |
Clusterin increases with age |
Molecular |
frontal lobe |
Human |
CLU |
25.5% Increase Gene Expression Level |
|
DAA2380 |
major histocompatibility complex, class I, C increases with age |
Molecular |
frontal lobe |
Human |
HLA-C |
56.5% Increase Gene Expression Level |
|
DAA2154 |
complement component 4B increases with age |
Molecular |
frontal lobe |
Human |
C4B |
895.9% Increase Gene Expression Level |
|
DAA2194 |
complement component 1, q subcomponent, A chain increases with age |
Molecular |
frontal lobe |
Human |
C1QA |
98.4% Increase Gene Expression Level |
|
DAA2349 |
major histocompatibility complex, class I-related increases with age |
Molecular |
frontal lobe |
Human |
MR1 |
22.4% Increase Gene Expression Level |
|
DAA2372 |
major histocompatibility complex, class II, DR beta 5 increases with age |
Molecular |
frontal lobe |
Human |
HLA-DRB5 |
64.1% Increase Gene Expression Level |
|